Nykode Therapeutics AS (NYKD.OL)
NOK 3.19
(-4.61%)
NOK 3.19
(-4.61%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 12.9 Million | 68.96 Million | 292.03 Million | 2.02 Billion | - | 129 Thousand |
| Cost of Revenue | -123.47 Million | - | - | - | 1.4 Million | 77.87 Million |
| Gross Profit | 136.38 Million | 68.96 Million | 292.03 Million | 2.02 Billion | -1.4 Million | -77.75 Million |
| Operating Expenses | 71.4 Million | 556.84 Million | 367.63 Million | 311.81 Million | 122.69 Million | - |
| Selling, General and Administrative Expenses | 6.27 Million | 249.66 Million | 205.75 Million | 206.96 Million | 59.53 Million | - |
| Research and Development Expenses | 51.2 Million | 257.58 Million | 140.15 Million | 100.03 Million | 61 Million | - |
| Other Expenses | 35.34 Million | -49.59 Million | -21.72 Million | -4.81 Million | -2.14 Million | - |
| Cost and Expenses | 70.98 Million | 574.28 Million | 373.96 Million | 314.67 Million | 124.1 Million | 77.87 Million |
| Operating Income | -58.08 Million | -505.32 Million | -81.93 Million | 1.7 Billion | -124.1 Million | -77.75 Million |
| Interest Expense | 224 Thousand | 241 Thousand | 130 Thousand | 46 Thousand | - | 6539.00 |
| Income Tax Expense | -8.93 Million | -79.27 Million | -14.65 Million | 293.04 Million | 1.00 | - |
| Earnings before Tax | -44.08 Million | -490.49 Million | -95.59 Million | 1.7 Billion | -120.55 Million | -63.79 Million |
| Net Income | -35.15 Million | -411.21 Million | -80.94 Million | 1.4 Billion | -120.55 Million | -63.79 Million |
| Earnings Per Share Basic | -0.12 | -1.42 | -0.28 | 5.04 | -0.09 | -0.23 |
| Earnings Per Share Diluted | -0.12 | -1.42 | -0.28 | 4.76 | -0.09 | -0.23 |
| Weighted Average Shares Outstanding | 300.52 Million | 290.11 Million | 286.34 Million | 279.64 Million | 1.36 Billion | 282.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 300.52 Million | 290.11 Million | 286.34 Million | 296.14 Million | 1.36 Billion | 282.79 Million |
| Gross Margin | 10.57 | 1.00 | 1.00 | 1.00 | - | -602.71 |
| EBIT Margin | -3.24 | -7.07 | -0.26 | 0.85 | - | -602.26 |
| Profit Margin | -2.72 | -5.96 | -0.28 | 0.70 | - | -494.52 |
| EBITDA | -41.74 Million | -52.74 Million | -10.25 Million | 181.25 Million | -12.53 Million | -7.6 Million |
| Earnings Before Tax Margin | -4.50 | -7.33 | -0.28 | 0.84 | - | -602.71 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 544 Thousand | 8.7 Million | 23.74 Million | 136.38 Million | 28.93 Million | 53.58 Million |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 544 Thousand | 8.7 Million | 23.74 Million | 136.38 Million | 28.93 Million | 53.58 Million |
| Operating Expenses | 12.33 Million | 168.98 Million | 204.49 Million | 714.14 Million | 174.27 Million | 176.8 Million |
| Selling, General and Administrative Expenses | 5.76 Million | 54.18 Million | 76.51 Million | - | 41.67 Million | 29.97 Million |
| Research and Development Expenses | 8.8 Million | 114.68 Million | 127.85 Million | - | 132.08 Million | 146.82 Million |
| Other Expenses | 3.53 Million | -115.72 Thousand | -119.19 Thousand | -44.58 Million | -513.67 Thousand | - |
| Cost and Expenses | 12.33 Million | 174.97 Million | 210.65 Million | 736.57 Million | 180 Million | 182.61 Million |
| Operating Income | -11.78 Million | -166.27 Million | -186.91 Million | -600.19 Million | -151.07 Million | -129.02 Million |
| Interest Expense | 50 Thousand | 53 Thousand | -2.9 Million | 224 Thousand | 1.68 Million | 821 Thousand |
| Income Tax Expense | -2.09 Million | -15.82 Million | -44.64 Million | -94.41 Million | -22.73 Million | -10.84 Million |
| Earnings before Tax | -9.48 Million | -173.05 Million | -102.48 Million | -466 Million | -130.12 Million | -109.56 Million |
| Net Income | -7.38 Million | -157.22 Million | -57.83 Million | -371.59 Million | -107.38 Million | -98.71 Million |
| Earnings Per Share Basic | -0.02 | -0.48 | -0.18 | - | -0.36 | -0.33 |
| Earnings Per Share Diluted | -0.02 | -0.48 | -0.18 | - | -0.36 | -0.33 |
| Weighted Average Shares Outstanding | 326.54 Million | 326.54 Million | 326.54 Million | 300.52 Million | 295.49 Million | 295.49 Million |
| Weighted Average Shares Outstanding (Diluted) | 326.54 Million | 326.54 Million | 326.54 Million | 300.52 Million | 295.49 Million | 295.49 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -16.30 | -18.42 | -7.61 | - | -5.02 | -2.30 |
| Profit Margin | -13.58 | -18.07 | -2.44 | -2.72 | -3.71 | -1.84 |
| EBITDA | -8.86 Million | -160.28 Million | -180.75 Million | - | -145.33 Million | -123.21 Million |
| Earnings Before Tax Margin | -21.67 | -19.11 | -7.87 | -4.40 | -5.22 | -2.41 |
UNIF
1271
HRAL
VINYOFL
4FY
7093